Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23316525)

1.

Genome study suggests new treatments for high-risk form of childhood leukemia.

McBride D.

ONS Connect. 2012 Nov;27(11):21. No abstract available.

PMID:
23316525
2.

Pharmacogenomics of childhood acute lymphoblastic leukemia.

Brenner TL, Pui CH, Evan WE.

Curr Opin Mol Ther. 2001 Dec;3(6):567-78. Review.

PMID:
11804271
3.

Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children.

Wall AM, Rubnitz JE.

Pharmacogenomics J. 2003;3(3):128-35. Review. No abstract available.

PMID:
12815362
4.

Pharmacogenetics of acute lymphoblastic leukemia treatment response.

Cunningham L, Aplenc R.

Expert Opin Pharmacother. 2007 Oct;8(15):2519-31. Review.

PMID:
17931087
5.

Pharmacogenetics in acute lymphoblastic leukemia.

Cheok MH, Pottier N, Kager L, Evans WE.

Semin Hematol. 2009 Jan;46(1):39-51. doi: 10.1053/j.seminhematol.2008.09.002. Review.

6.

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.

Relling MV, Ramsey LB.

Hematology Am Soc Hematol Educ Program. 2013;2013:126-30. doi: 10.1182/asheducation-2013.1.126. Review.

7.

Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.

Davidsen ML, Dalhoff K, Schmiegelow K.

J Pediatr Hematol Oncol. 2008 Nov;30(11):831-49. doi: 10.1097/MPH.0b013e3181868570. Review.

PMID:
18989161
8.

Biology and treatment of acute lymphoblastic leukemia.

Pieters R, Carroll WL.

Pediatr Clin North Am. 2008 Feb;55(1):1-20, ix. doi: 10.1016/j.pcl.2007.11.002. Review.

PMID:
18242313
9.

The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.

Aricó M, Baruchel A, Bertrand Y, Biondi A, Conter V, Eden T, Gadner H, Gaynon P, Horibe K, Hunger SP, Janka-Schaub G, Masera G, Nachman J, Pieters R, Schrappe M, Schmiegelow K, Valsecchi MG, Pui CH.

Leukemia. 2005 Jul;19(7):1145-52.

PMID:
15902295
10.

Chemotherapy of acute myelocytic leukemia in children.

Lie SO, Jonmundsson GK, Mellander L, Siimes MA, Yssing M, Gustafsson G.

Ann N Y Acad Sci. 1997 Sep 17;824:84-90. Review. No abstract available.

PMID:
9382458
11.

Standard and intermediate risk acute lymphoblastic leukemia in Poland: a report of the Polish Children's Leukemia/Lymphoma Study Group.

Radwanska U, Michalewska D, Kolecki P, Armata J, Balwierz W, Boguslawska-Jaworska J, Chybicka A, Cyklis R, Kowalczyk J, Ochocka M, et al.

Acta Paediatr Jpn. 1995 Feb;37(1):31-6.

PMID:
7754762
12.

Treatment of pediatric acute lymphoblastic leukemia.

Tucci F, Aricò M.

Haematologica. 2008 Aug;93(8):1124-8. doi: 10.3324/haematol.13517. No abstract available.

13.

[New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia].

Usui N.

Rinsho Ketsueki. 2006 Apr;47(4):294-302. Review. Japanese. No abstract available.

PMID:
16715964
14.

Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.

Cheok MH, Evans WE.

Nat Rev Cancer. 2006 Feb;6(2):117-29. Review. Erratum in: Nat Rev Cancer. 2006 Mar;6(3):249.

PMID:
16491071
15.

Pharmacogenomics in pediatric leukemia.

Paugh SW, Stocco G, Evans WE.

Curr Opin Pediatr. 2010 Dec;22(6):703-10. doi: 10.1097/MOP.0b013e32833fde85. Review.

16.

St Jude researchers use DNA chips to determine how leukemia cells responds to different drug treatments.

[No authors listed]

Pharmacogenomics. 2003 May;4(3):244. No abstract available.

PMID:
12774778
17.

[High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].

Castell V, Verdaguer A, Ferris J, Piqueras AI, Fernández JM.

An Esp Pediatr. 1988 Oct;29 Suppl 34:89-91. Spanish. No abstract available.

PMID:
3214045
18.

[High-risk acute lymphoblastic leukemia].

Martínez Rubio A, Doñoro Mazario M, Sánchez Luna M, Muro Brussi M, Lamamie de Cleirac P, García-Monge Santidrián S.

An Esp Pediatr. 1988 Oct;29 Suppl 34:66-8. Spanish. No abstract available.

PMID:
3214041
19.

Childhood acute lymphoblastic leukemia: update on prognostic factors.

Vrooman LM, Silverman LB.

Curr Opin Pediatr. 2009 Feb;21(1):1-8. doi: 10.1097/MOP.0b013e32831f1f24. Review.

PMID:
19242236
20.

Chemotherapy or allografting for young adults with high-risk ALL?

Anasetti C.

Blood. 2008 Jun 15;111(12):5755; author reply 5755. doi: 10.1182/blood-2008-03-147272. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk